久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Ipsen and Saol partner to co-promote Dysport in US pharmaceutical-technology
    July 04, 2017
    The US affiliate of French pharmaceutical company Ipsen has entered an exclusive, three-year agreement with Saol Therapeutics to promote Dysport (abobotulinumtoxinA) for approved therapeutic indications in adult spasticity and pediatric lower limb spastic

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service